[Basic pharmacological research on the hypoglycemic action of N-4-[beta-(2-methoxy-5-chlorbenzamide)-ethyl]-benzosulfonyl-N'-cyclohexylurea (Glybenclamide)].
D000014:Abnormalities, Drug-Induced; D000818:Animals; D001774:Blood Chemical Analysis; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy*; D004285:Dogs; D005260:Female; D005333:Fetus / Q000187:drug effects; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000032:analysis / Q000097:blood / Q000494:pharmacology* / Q000627:therapeutic use* / Q000633:toxicity; D008099:Liver / Q000187:drug effects; D008111:Liver Function Tests; D008112:Liver Glycogen / Q000378:metabolism; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D014044:Tolbutamide / Q000494:pharmacology / Q000633:toxicity
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D008112:Liver Glycogen; D014044:Tolbutamide